Opioids

496 Results

number of items to display at a time

Research

May 1, 2026

State Tele-Buprenorphine Prescribing Policies by Medical Professional Type

Systematic legal mapping of all 50 states finds wide variation in tele-buprenorphine policy support for Medicaid enrollees, with six states prohibiting virtual OUD care and NPs and PAs facing greater barriers than physicians.
Research

Apr 10, 2026

Assessing Bias and Precision in State Policy Evaluations: A Comparative Analysis of Time-Varying Estimators Using Policy Simulations

Using state-level opioid overdose mortality data (1999-2016), we evaluated the performance of panel data estimators for capturing time-varying impacts of state-level policies.
Research

Apr 9, 2026

Autoregressive Models for Panel Data Causal Inference with Application to State-Level Opioid Policies

Motivated by the study of state opioid policies, we propose a novel approach that uses autoregressive models for causal effect estimation in settings with panel data and staggered treatment adoption.
Research

Mar 18, 2026

Examining the Potential Role of Opioid Settlement Funds in the Face of Impending Federal Budget Reductions for Substance Use Disorders

The objective of this paper is to assess the potential of opioid settlement dollars disbursed to state and local governments to replace or supplement federal substance use disorder funding.
Research

Mar 11, 2026

Higher Suicidality Among Primary Care Patients Who Have Opioid Use Disorder and Co-Occurring Depression And/Or PTSD

We compared the characteristics of three groups of patients who screened positive for OUD and depression and/or PTSD and examined how membership in these groups was associated with suicidality and treatment.
Research

Jan 20, 2026

A Qualitative Study of Patients’ Experiences With Collaborative Care for Co-occurring Opioid Use and Mental Health Disorders in Primary Care

We sought to understand patients’ experiences receiving collaborative care model for co-occurring opioid use disorder and depression and/or PTSD.
Research

Jan 16, 2026

Variation in Naloxone and Buprenorphine Prescribing in LA County's Safety-Net System

To describe patients and visits with identified, probable opioid use disorder in Los Angeles County's safety-net system, and examine rates of naloxone and buprenorphine prescribing across healthcare settings.
Research

Jan 15, 2026

Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial

To determine whether collaborative care, tailored for low-resource settings, improves outcomes for patients with OUD and co-occurring depression and/or PTSD more so than enhanced usual care.
Research

Dec 29, 2025

Collaborative Care Model for Patients With Opioid Use Disorder and Mental Illness

The present study used data from a CoCM trial for OUD co-occurring with mental illness to examine patient characteristics associated with CoCM engagement and fidelity.
Research

Oct 3, 2025

Over-the-Counter Retail Naloxone Sales

First-year US OTC naloxone sales were low, peaking then stabilizing far below pharmacy or program distribution rates. High prices and limited uptake suggest OTC access has not filled distribution gaps; further research on demand drivers is needed.
Research

Oct 2, 2025

Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes

Medicaid unwinding led to more buprenorphine treatment episodes ending (+3%) and fewer starting (-2.6%) among Medicaid patients, with greatest impact in high-disenrollment states; losses were not offset by other payers, risking treatment disruption.
Press

Sep 29, 2025

Medicaid Unwinding Associated with Less Medication Treatment for Opioid Use Disorder

The end of pandemic-era enrollment enhancements for Medicaid was associated with a rise in the number of people ending medication treatment for opioid use disorder, as well as a decrease in the number of people beginning such treatment.

First
Previous
Page 1 of 42
Next
Last

Opioids

Opioids

Related Topics

How the Opioid Crisis Affects Older Adults

America's Opioid Ecosystem

Explore RAND’s Work on this Topic

Error

State Tele-Buprenorphine Prescribing Policies by Medical Professional Type

Assessing Bias and Precision in State Policy Evaluations: A Comparative Analysis of Time-Varying Estimators Using Policy Simulations

Autoregressive Models for Panel Data Causal Inference with Application to State-Level Opioid Policies

Examining the Potential Role of Opioid Settlement Funds in the Face of Impending Federal Budget Reductions for Substance Use Disorders

Higher Suicidality Among Primary Care Patients Who Have Opioid Use Disorder and Co-Occurring Depression And/Or PTSD

A Qualitative Study of Patients’ Experiences With Collaborative Care for Co-occurring Opioid Use and Mental Health Disorders in Primary Care

Variation in Naloxone and Buprenorphine Prescribing in LA County's Safety-Net System

Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial

Collaborative Care Model for Patients With Opioid Use Disorder and Mental Illness

Over-the-Counter Retail Naloxone Sales

Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes

Medicaid Unwinding Associated with Less Medication Treatment for Opioid Use Disorder

Oops! An unexpected error has occurred.

RAND Headquarters

U.S. research divisions

International research divisions

Opioids

Opioids

Related Topics

How the Opioid Crisis Affects Older Adults

America's Opioid Ecosystem

Explore RAND’s Work on this Topic

Error

State Tele-Buprenorphine Prescribing Policies by Medical Professional Type

Assessing Bias and Precision in State Policy Evaluations: A Comparative Analysis of Time-Varying Estimators Using Policy Simulations

Autoregressive Models for Panel Data Causal Inference with Application to State-Level Opioid Policies

Examining the Potential Role of Opioid Settlement Funds in the Face of Impending Federal Budget Reductions for Substance Use Disorders

Higher Suicidality Among Primary Care Patients Who Have Opioid Use Disorder and Co-Occurring Depression And/Or PTSD

A Qualitative Study of Patients’ Experiences With Collaborative Care for Co-occurring Opioid Use and Mental Health Disorders in Primary Care

Variation in Naloxone and Buprenorphine Prescribing in LA County's Safety-Net System

Collaborative Care for Opioid Use Disorder and Mental Illness: The CLARO Randomized Clinical Trial

Collaborative Care Model for Patients With Opioid Use Disorder and Mental Illness

Over-the-Counter Retail Naloxone Sales

Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes

Medicaid Unwinding Associated with Less Medication Treatment for Opioid Use Disorder

Oops! An unexpected error has occurred.